High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer

PURPOSE: High-dose-rate (HDR) brachytherapy has been accepted as an effective and safe method to treat prostate cancer. The aim of this study was to describe acute toxicity following HDR brachytherapy to the prostate, and to examine the association between dosimetric parameters and urinary toxicity...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Contemp Brachytherapy
Main Authors: Cendales, Ricardo, Alwers, Elizabeth, Cifuentes, Javier, Bobadilla, Ivan, Torres, Felipe, Arbelaez, Juan, Gaitan, Armando, Cortes, Helber, Acevedo, Yenny, Quintero, Paulo, Vasquez, Jaider
Formato: Artigo
Idioma:Inglês
Publicado: Termedia Publishing House 2015
Assuntos:
Original Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4371062/
https://ncbi.nlm.nih.gov/pubmed/25829931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2015.48838
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares